DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pruvanserin
Pruvanserin
(12) United States Patent (10) Patent No.: US 8.598,119 B2 Mates Et Al
A Phase 3, Multicenter, Randomized, Double-Blind
Emerging Anti-Insomnia Drugs: Tackling Sleeplessness and the Quality of Wake Time
(12) Patent Application Publication (10) Pub. No.: US 2015/0072964 A1 Mates Et Al
United States Patent (10 ) Patent No.: US 10,660,887 B2 Javitt (45 ) Date of Patent: *May 26 , 2020
Copyright by Holly L. Chapman 2020
| Hai Lama at Matalun Alun Alt Palma Hati
( 12 ) United States Patent
Treatment of Chronic Pain by Medical Approaches the AMERICAN ACADEMY of PAIN MEDICINE Textbook on Patient Management Treatment of Chronic Pain by Medical Approaches
WO 2020/212952 A1 22 October 2020 (22.10.2020)
Stembook 2018.Pdf
Pimavanserin Tartrate: a 5-HT2A Inverse Agonist with Potential for Treating Various 1
Pigeon 48 1..8
Combinations of 5-Ht2a Inverse Agonists And
Serotonin Receptors and Drugs Affecting Serotonergic Neurotransmission R ICHARD A
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled
(12) United States Patent (10) Patent No.: US 9.428,506 B2 Mates Et Al
(12) United States Patent (10) Patent No.: US 9.486.453 B2 Javitt (45) Date of Patent: Nov
Top View
Role of 5-HT Receptor Antagonists in the Treatment of Insomnia
Annual Report 2010 Annual Report 2010 Corporate Profile
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
(12) Patent Application Publication (10) Pub. No.: US 2010/01792 15 A1 Dube Et Al
Customs Tariff - Schedule
Pharmaabkommen A1 E
(12) United States Patent (10) Patent No.: US 8,617,577 B2 Crain Et Al
Customs Tariff - Schedule Xxi - 1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Study Protocol
Flumazenil N O—N
A61p25/06 (2006.01) A61p25/22 (2006.01)
( 12 ) United States Patent
Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Managing Insomnia
Kara Panetta Thesis
New Approaches Towards Treatment of Insomnia
5-HT2A Blockade for Dyskinesia and Psychosis in Parkinson's Disease: Is There a Limit to the Efficacy of This Approach? a Stud
Effects of a Serotonin 2C Agonist and a 2A Antagonist on Actigraphy-Based Sleep Parameters Disrupted by Methamphetamine Self-Administration in Rhesus Monkeys
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances